Goldman Sachs Group Inc. Raises Stock Holdings in Agilent Technologies, Inc. $A

Goldman Sachs Group Inc. increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 21.9% in the fourth quarter, HoldingsChannel reports. The firm owned 3,083,977 shares of the medical research company’s stock after buying an additional 554,690 shares during the period. Goldman Sachs Group Inc.’s holdings in Agilent Technologies were worth $419,637,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Core Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter worth $26,000. Board of the Pension Protection Fund purchased a new stake in shares of Agilent Technologies during the 4th quarter worth $27,000. Navalign LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter worth $27,000. Physician Wealth Advisors Inc. lifted its stake in shares of Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after purchasing an additional 196 shares during the last quarter. Finally, Entrust Financial LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter worth $31,000.

Agilent Technologies Trading Up 0.6%

Shares of NYSE:A opened at $138.23 on Friday. The business’s 50-day moving average is $117.89 and its 200 day moving average is $128.30. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The firm has a market capitalization of $39.04 billion, a P/E ratio of 27.76, a P/E/G ratio of 2.45 and a beta of 1.26. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the prior year, the company posted $1.31 EPS. The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.99 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Analyst Ratings Changes

A has been the subject of a number of analyst reports. TD Cowen upped their price objective on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Robert W. Baird upped their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Barclays upped their target price on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. UBS Group reduced their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, Royal Bank Of Canada began coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $161.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.